GB virus C

Last updated
Pegivirus C
Virus classification OOjs UI icon edit-ltr.svg
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum: Kitrinoviricota
Class: Flasuviricetes
Order: Amarillovirales
Family: Flaviviridae
Genus: Pegivirus
Species:
Pegivirus C

GB virus C (GBV-C), formerly known as hepatitis G virus (HGV) and also known as human pegivirus (HPgV), is a virus in the family Flaviviridae and a member of the Pegivirus . [1] It is known to infect humans but is not known to cause human disease. Reportedly, HIV patients coinfected with GBV-C can survive longer than those without GBV-C, but the patients may be different in other ways. Research is active into the virus' effects on the immune system in patients coinfected with GBV-C and HIV. [2] [3] [4]

Contents

Human infection

The majority of immunocompetent individuals clear GBV-C viraemia, but in some individuals, infection persists for decades. [5] However, the time interval between GBV-C infection and clearance of viraemia (detection of GBV-C RNA in plasma) is not known.

About 2% of healthy US blood donors are viraemic with GBV-C, and up to 13% of blood donors have antibodies to E2 protein, indicating possible prior infection. [5]

Parenteral, sexual, and vertical transmissions of GBV-C have been documented. Because of shared modes of transmission, individuals infected with HIV are often coinfected with GBV-C; the prevalence of GBV-C viraemia in HIV patients ranges from 14 to 43%. [6]

Several but not all studies have suggested that coinfection with GBV-C slows the progression of HIV disease. [7] In vitro models also demonstrated that GBV-C slows HIV replication. This beneficial effect may be related to action of several GBV-C viral proteins, including NS5A phosphoprotein and E2 envelope protein. [8]

Virology

It has a single-stranded, positive-sense RNA genome of about 9.3 kb and contains a single open reading frame (ORF) encoding two structural (E1 and E2) and five nonstructural (NS2, NS3, NS4, NS5A, and NS5B) proteins. GB-C virus does not appear to encode a C (core or nucleocapsid) protein like, for instance, hepatitis C virus. Nevertheless, viral particles have been found to have a nucleocapsid. The source of the nucleocapsid protein remains unknown. [1]

Taxonomy

GBV-C is a member of the family Flaviviridae and is phylogenetically related to hepatitis C virus, but replicates primarily in lymphocytes, and poorly, if at all, in hepatocytes. [9] [10] GBV-A and GBV-B are probably tamarin viruses, while GBV-C infects humans. [11] The GB viruses have been tentatively assigned to a fourth genus within the Flaviviridae named "Pegivirus", but this has yet to be formally endorsed by the International Committee on Taxonomy of Viruses. [12]

Another member of this clade, GBV-D, has been isolated from a bat ( Pteropus giganteus ). [13] GBV-D may be ancestral to GBV-A and GBV-C. [13]

The mutation rate of the GBV-C genome has been estimated at 10−2 to 10−3 substitutions/site/year. [14]

Epidemiology

GBV-C infection has been found worldwide and currently infects around a sixth of the world's population. High prevalence is observed among subjects with the risk of parenteral exposures, including those with exposure to blood and blood products, those on hemodialysis, and intravenous drug users. Sexual contact and vertical transmission may occur. About 10–25% of hepatitis C-infected patients and 14–36% of drug users who are seropositive for HIV-1 show the evidence of GBV-C infection.

It has been classified into seven genotypes and many subtypes with distinct geographical distributions. [15] Genotypes 1 and 2 are prevalent in Northern and Central Africa and in Americas. Genotypes 3 and 4 are commons in Asia. Genotype 5 is present in Central and Southern Africa. Genotype 6 can be encountered in Southeast Asia. Finally, genotype 7 has been reported in China. Infection with multiple genotypes is possible. [16]

Genotype 5 appears to be basal in the phylogenetic tree, suggesting an African origin for this virus. [17]

History

Hepatitis G virus and GB virus C (GBV-C) are RNA viruses that were independently identified in 1995, and were subsequently found to be two isolates of the same virus. [18] [19] [20] [21] Although GBV-C was initially thought to be associated with chronic hepatitis, extensive investigation failed to identify any association between this virus and any clinical illness. [22] GB Virus C (and indeed, GBV-A and GBV-B) is named after the surgeon, G. Barker, who fell ill in 1966 with a non-A non-B hepatitis which at the time was thought to have been caused by a new, infectious hepatic virus. [23]

See also

Related Research Articles

<span class="mw-page-title-main">Hepatitis C</span> Human viral infection

Hepatitis C is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver; it is a type of viral hepatitis. During the initial infection period, people often have mild or no symptoms. Early symptoms can include fever, dark urine, abdominal pain, and yellow tinged skin. The virus persists in the liver, becoming chronic, in about 70% of those initially infected. Early on, chronic infection typically has no symptoms. Over many years however, it often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop serious complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.

<i>Flaviviridae</i> Family of viruses

Flaviviridae is a family of enveloped positive-strand RNA viruses which mainly infect mammals and birds. They are primarily spread through arthropod vectors. The family gets its name from the yellow fever virus; flavus is Latin for "yellow", and yellow fever in turn was named because of its propensity to cause jaundice in victims. There are 89 species in the family divided among four genera. Diseases associated with the group include: hepatitis (hepaciviruses), hemorrhagic syndromes, fatal mucosal disease (pestiviruses), hemorrhagic fever, encephalitis, and the birth defect microcephaly (flaviviruses).

Hepatitis D is a type of viral hepatitis caused by the hepatitis delta virus (HDV). HDV is one of five known hepatitis viruses: A, B, C, D, and E. HDV is considered to be a satellite because it can propagate only in the presence of the hepatitis B virus (HBV). Transmission of HDV can occur either via simultaneous infection with HBV (coinfection) or superimposed on chronic hepatitis B or hepatitis B carrier state (superinfection).

<span class="mw-page-title-main">Hepatitis A</span> Acute infectious disease of the liver

Hepatitis A is an infectious disease of the liver caused by Hepatovirus A (HAV); it is a type of viral hepatitis. Many cases have few or no symptoms, especially in the young. The time between infection and symptoms, in those who develop them, is two–six weeks. When symptoms occur, they typically last eight weeks and may include nausea, vomiting, diarrhea, jaundice, fever, and abdominal pain. Around 10–15% of people experience a recurrence of symptoms during the 6 months after the initial infection. Acute liver failure may rarely occur, with this being more common in the elderly.

<span class="mw-page-title-main">Viral hepatitis</span> Liver inflammation from a viral infection

Viral hepatitis is liver inflammation due to a viral infection. It may present in acute form as a recent infection with relatively rapid onset, or in chronic form, typically progressing from a long-lasting asymptomatic condition up to a decompensated hepatic disease and hepatocellular carcinoma (HCC).

<span class="mw-page-title-main">Parvovirus B19</span> Human virus that infects RBC precursors

Human parvovirus B19, generally referred to as B19 virus(B19V),parvovirus B19 or sometimes erythrovirus B19, is a known human virus in the family Parvoviridae, genus Erythroparvovirus; it measures only 23–26 nm in diameter. Human parvovirus b19 is a below-species classification of Erythroparvovirus primate1. The name is derived from Latin parvum, meaning small, reflecting the fact that B19 ranks among the smallest DNA viruses. B19 virus is most known for causing disease in the pediatric population; however, it can also affect adults. It is the classic cause of the childhood rash called fifth disease or erythema infectiosum, or "slapped face syndrome". The name comes from it being the fifth in a list of historical classifications of common skin rash illnesses in children.

Coinfection is the simultaneous infection of a host by multiple pathogen species. In virology, coinfection includes simultaneous infection of a single cell by two or more virus particles. An example is the coinfection of liver cells with hepatitis B virus and hepatitis D virus, which can arise incrementally by initial infection followed by superinfection.

<span class="mw-page-title-main">Hepatitis C virus</span> Species of virus

The hepatitis C virus (HCV) is a small, enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. The hepatitis C virus is the cause of hepatitis C and some cancers such as liver cancer and lymphomas in humans.

<i>Hepacivirus</i> Genus of viruses

Hepacivirus is a genus of positive-strand RNA viruses in the family Flaviviridae. The hepatitis C virus (HCV), in species Hepacivirus C, infects humans and is associated with hepatitis and hepatocellular carcinoma. There are fourteen species in the genus which infect a range of other vertebrate.

Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infection is a multi-faceted, chronic condition that significantly impacts public health. According to the World Health Organization (WHO), 2 to 15% of those infected with HIV are also affected by HCV, increasing their risk of morbidity and mortality due to accelerated liver disease. The burden of co-infection is especially high in certain high-risk groups, such as intravenous drug users and men who have sex with men. These individuals who are HIV-positive are commonly co-infected with HCV due to shared routes of transmission including, but not limited to, exposure to HIV-positive blood, sexual intercourse, and passage of the Hepatitis C virus from mother to infant during childbirth.

Visna-maedi virus from the genus Lentivirus and subfamily Orthoretrovirinae, is a retrovirus that causes encephalitis and chronic pneumonitis in sheep. It is known as visna when found in the brain, and maedi when infecting the lungs. Lifelong, persistent infections in sheep occur in the lungs, lymph nodes, spleen, joints, central nervous system, and mammary glands; The condition is sometimes known as ovine progressive pneumonia (OPP), particularly in the United States, or Montana sheep disease. White blood cells of the monocyte/macrophage lineage are the main target of the virus.

Non-A-E hepatitis, also known as hepatitis X, is an infectious disease of the liver referring to a case of viral hepatitis that cannot be attributed to hepatitis A, B, C, D, or E. The disease involves swelling and inflammation of the liver. Symptoms of non-A-E hepatitis may include tiredness, nausea, vomiting, abdomen pain, and a fever. The specific cause of non-A-E hepatitis is unknown. It is considered a rare disorder.

<i>Hepatitis B virus</i> Species of the genus Orthohepadnavirus

Hepatitis B virus (HBV) is a partially double-stranded DNA virus, a species of the genus Orthohepadnavirus and a member of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.

<i>Pegivirus</i> Genus of viruses

Pegivirus is the approved name for a genus of single positive-stranded RNA viruses in the family Flaviviridae. The name is a derived one: "Pe" stands for "persistent" and "g" is a reference to Hepatitis G, a former name of the C species.

Infections of the hepatitis C virus (HCV) in children and pregnant women are less understood than those in other adults. Worldwide, the prevalence of HCV infection in pregnant women and children has been estimated to 1-8% and 0.05-5% respectively. The vertical transmission rate has been estimated to be 3-5% and there is a high rate of spontaneous clearance (25-50%) in the children. Higher rates have been reported for both vertical transmission. and prevalence in children (15%).

Aichivirus A formerly Aichi virus (AiV) belongs to the genus Kobuvirus in the family Picornaviridae. Six species are part of the genus Kobuvirus, Aichivirus A-F. Within Aichivirus A, there are six different types including human Aichi virus, canine kobuvirus, murine kobuvirus, Kathmandu sewage kobuvirus, roller kobuvirus, and feline kobuvirus. Three different genotypes are found in human Aichi virus, represented as genotype A, B, and C.

<span class="mw-page-title-main">Beclabuvir</span> Chemical compound

Beclabuvir is an antiviral drug for the treatment of hepatitis C virus (HCV) infection that has been studied in clinical trials. In February 2017, Bristol-Myers Squibb began sponsoring a post-marketing trial of beclabuvir, in combination with asunaprevir and daclatasvir, to study the combination's safety profile with regard to liver function. From February 2014 to November 2016, a phase II clinical trial was conducted on the combination of asunaprevir/daclatasvir/beclabuvir on patients infected with both HIV and HCV. Furthermore, a recent meta-analysis of six published six clinical trials showed high response rates in HCV genotype 1-infected patients treated with daclatasvir, asunaprevir, and beclabuvir irrespective of ribavirin use, prior interferon-based therapy, or restriction on noncirrhotic patients, IL28B genotype, or baseline resistance-associated variants

Elbasvir/grazoprevir, sold under the brand name Zepatier, is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir and grazoprevir. It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and treatment-experienced patients.

HPgV-2 is the second human pegivirus discovered. It was first identified in 2005 in blood of transfusion recipients and initially named hepegivirus 1 because it shared some genetic features with both pegiviruses and hepaciviruses. HPgV-2 was later independently discovered by another group in the blood of a HCV-infected patient who had undergone multiple blood transfusions and died from sepsis of unclear etiology. It was then named human pegivirus 2. HPgV-2 is now classified in the pegivirus genus as part of Pegivirus H species.

<span class="mw-page-title-main">Epidemiology of hepatitis D</span> Instance, distribution, and control of Hepatitis D

The epidemiology of hepatitis D occurs worldwide. Although the figures are disputed, a recent systematic review suggests that up to 60 million individuals could be infected. The major victims are the carriers of the hepatitis B surface antigen (HBsAg), who become superinfected by the HDV, and intravenous drug users who are the group at highest risk. The infection usually results in liver damage ; this is most often a chronic and severe hepatitis rapidly conducive to cirrhosis.

References

  1. 1 2 Stapleton, J. T.; Foung, S.; Muerhoff, A. S.; Bukh, J.; Simmonds, P. (2010). "The GB viruses: A review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae". Journal of General Virology. 92 (2): 233–46. doi:10.1099/vir.0.027490-0. PMC   3081076 . PMID   21084497.
  2. ↑ Xiang J, George SL, Wünschmann S, et al. (2004). "Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1". Lancet. 363 (9426): 2040–6. doi:10.1016/S0140-6736(04)16453-2. PMID   15207954. S2CID   54317667.
  3. ↑ Mosam A, Sathar MA, Dawood H, Cassol E, Esterhuizen TM, Coovadia HM (2007). "Effect of GB Virus C Co-infection on Response to Generic HAART in African Patients with HIV-1 Clade C Infection". AIDS. 21 (10): 1377–9. doi: 10.1097/QAD.0b013e3281532cb8 . PMID   17545721. S2CID   19630054.
  4. ↑ Jung S, Eichenmüller M, Donhauser N, et al. (2007). "HIV Entry Inhibition by the Envelope 2 Glycoprotein of GB Virus C". AIDS. 21 (5): 645–7. doi: 10.1097/QAD.0b013e32803277c7 . PMID   17314528. S2CID   45809720.
  5. 1 2 "Hepatitis G". My Health and Nutrition. Archived from the original on 2013-11-02.
  6. ↑ George SL, Varmaz D, Stapleton JT (2006). "GB Virus C Replicates in Primary T and B Lymphocytes". J. Infect. Dis. 193 (3): 451–4. doi: 10.1086/499435 . PMID   16388494.
  7. ↑ Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT (2006). "Effect of Early and Late GB Virus C Viraemia on Survival of HIV-infected Individuals: A Meta-analysis". HIV Med. 7 (3): 173–180. doi: 10.1111/j.1468-1293.2006.00366.x . PMID   16494631.
  8. ↑ Giret, M. T. M.; Kallas, E. G. (March 2012). "GBV-C: State of the Art and Future Prospects". Current HIV/AIDS Reports. 9 (1): 26–33. doi:10.1007/s11904-011-0109-1. PMID   22246585. S2CID   22887740.
  9. ↑ Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1996). "Sequence and Genomic Organization of GBV-C: A Novel Member of the Flaviviridae Associated with Human Non-A–E Hepatitis". J. Med. Virol. 48 (1): 60–7. doi:10.1002/(SICI)1096-9071(199601)48:1<60::AID-JMV10>3.0.CO;2-A. PMID   8825712. S2CID   28977057.
  10. ↑ Thurner C, Witwer C, Hofacker IL, Stadler PF (May 2004). "Conserved RNA Secondary Structures in Flaviviridae Genomes". J. Gen. Virol. 85 (Pt 5): 1113–24. doi: 10.1099/vir.0.19462-0 . PMID   15105528.
  11. ↑ Simons JN, Desai SM, Schultz DE, Lemon SM, Mushahwar IK (1996). "Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization". J. Virol. 70 (9): 6126–35. doi:10.1128/JVI.70.9.6126-6135.1996. PMC   190635 . PMID   8709237.
  12. ↑ Stapleton JT, Foung S, Muerhoff AS, Bukh J, Simmonds P (February 2011). "The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae". The Journal of General Virology. 92 (Pt 2): 233–46. doi:10.1099/vir.0.027490-0. PMC   3081076 . PMID   21084497.
  13. 1 2 Epstein JH, Quan PL, Briese T, et al. (2010). "Identification of GBV-D, a novel GB-like flavivirus from Old World frugivorous bats (Pteropus giganteus) in Bangladesh". PLOS Pathog. 6 (7): e1000972. doi: 10.1371/journal.ppat.1000972 . PMC   2895649 . PMID   20617167.
  14. ↑ Romano CM, Zanotto PM, Holmes EC (March 2008). "Bayesian coalescent analysis reveals a high rate of molecular evolution in GB virus C". J. Mol. Evol. 66 (3): 292–7. Bibcode:2008JMolE..66..292R. doi:10.1007/s00239-008-9087-3. PMC   3324782 . PMID   18320258.
  15. ↑ Feng Y, Zhao W, Feng Y, Dai J, Li Z, Zhang X, Liu L, Bai J, Zhang H, Lu L, Xia X (2011). Davis T (ed.). "A Novel Genotype of GB Virus C: Its Identification and Predominance among Injecting Drug Users in Yunnan, China". PLOS ONE. 6 (10): e21151. Bibcode:2011PLoSO...621151F. doi: 10.1371/journal.pone.0021151 . PMC   3188531 . PMID   21998624.
  16. ↑ Singh, Shivank; Blackard, Jason T (2017). "Human pegivirus (HPgV) infection in sub-Saharan Africa-A call for a renewed research agenda". Reviews in Medical Virology. 27 (6): e1951. doi:10.1002/rmv.1951. PMID   29148108. S2CID   4061848.
  17. ↑ Muerhoff AS, Leary TP, Sathar MA, Dawson GJ, Desai SM (June 2005). "African origin of GB virus C determined by phylogenetic analysis of a complete genotype 5 genome from South Africa". J. Gen. Virol. 86 (Pt 6): 1729–35. doi: 10.1099/vir.0.80854-0 . PMID   15914851.
  18. ↑ Simons JN, Pilot-Matias TJ, Leary TP, et al. (April 1995). "Identification of two flavivirus-like genomes in the GB hepatitis agent". Proc. Natl. Acad. Sci. USA. 92 (8): 3401–5. Bibcode:1995PNAS...92.3401S. doi: 10.1073/pnas.92.8.3401 . PMC   42174 . PMID   7724574.
  19. ↑ Simons JN, Leary TP, Dawson GJ, et al. (June 1995). "Isolation of Novel Virus-like Sequences Associated with Human Hepatitis". Nat. Med. 1 (6): 564–9. doi:10.1038/nm0695-564. PMID   7585124. S2CID   27358642.
  20. ↑ Yoshiba M, Okamoto H, Mishiro S (October 1995). "Detection of the GBV-C Hepatitis Virus Genome in Serum from Patients with Fulminant Hepatitis of Unknown Aetiology". Lancet. 346 (8983): 1131–2. doi:10.1016/S0140-6736(95)91802-7. PMID   7475605. S2CID   42480382.
  21. ↑ Birkenmeyer LG, Desai SM, Muerhoff AS, Leary TP, Simons JN, Montes CC, Mushahwar IK (1998). "Isolation of a GB Virus-related Genome from a Chimpanzee". J. Med. Virol. 56 (1): 44–51. doi: 10.1002/(SICI)1096-9071(199809)56:1<44::AID-JMV8>3.0.CO;2-N . PMID   9700632. S2CID   38749195.
  22. ↑ Alter, H. J. (June 1996). "The Cloning and Clinical Implications of HGV and HGBV-C". N. Engl. J. Med. 334 (23): 1536–7. doi:10.1056/NEJM199606063342310. PMID   8618611.
  23. ↑ Reshetnyak, VI; Karlovich, TI; Ilchenko, LU (2008). "Hepatitis G virus". World Journal of Gastroenterology. 14 (30): 4725–34. doi: 10.3748/wjg.14.4725 . PMC   2739332 . PMID   18720531.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.